Bernard Gordon R 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Dec 6, 2019
Insider Transaction Report
Form 4
Bernard Gordon R
Senior Vice President
Transactions
- Sale
Common Stock
2019-12-04$4.79/sh−1,000$4,790→ 0 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies.